The following companies are expected to report earnings prior to market open on 02/02/2024. Visit our Earnings Calendar for a full list of expected earnings releases.
Exxon Mobil Corporation (XOM)is reporting for the quarter ending December 31, 2023. The oil company's consensus earnings per share forecast from the 8 analysts that follow the stock is $2.21. This value represents a 35.00% decrease compared to the same quarter last year. The last two quarters XOM had negative earnings surprises; the latest report they missed by -3.81%. Zacks Investment Research reports that the 2023 Price to Earnings ratio for XOM is 11.11 vs. an industry ratio of 6.80, implying that they will have a higher earnings growth than their competitors in the same industry.
AbbVie Inc. (ABBV)is reporting for the quarter ending December 31, 2023. The large cap pharmaceutical company's consensus earnings per share forecast from the 8 analysts that follow the stock is $2.76. This value represents a 23.33% decrease compared to the same quarter last year. In the past year ABBV has beat the expectations every quarter. The highest one was in the 3rd calendar quarter where they beat the consensus by 3.15%. Zacks Investment Research reports that the 2023 Price to Earnings ratio for ABBV is 14.81 vs. an industry ratio of 29.80.
Chevron Corporation (CVX)is reporting for the quarter ending December 31, 2023. The oil company's consensus earnings per share forecast from the 8 analysts that follow the stock is $3.29. This value represents a 19.56% decrease compared to the same quarter last year. Zacks Investment Research reports that the 2023 Price to Earnings ratio for CVX is 11.37 vs. an industry ratio of 6.80, implying that they will have a higher earnings growth than their competitors in the same industry.
Regeneron Pharmaceuticals, Inc. (REGN)is reporting for the quarter ending December 31, 2023. The biomedical (gene) company's consensus earnings per share forecast from the 9 analysts that follow the stock is $9.10. This value represents a 16.97% decrease compared to the same quarter last year. In the past year REGN has beat the expectations every quarter. The highest one was in the 3rd calendar quarter where they beat the consensus by 8.31%. Zacks Investment Research reports that the 2023 Price to Earnings ratio for REGN is 26.26 vs. an industry ratio of -1.60, implying that they will have a higher earnings growth than their competitors in the same industry.
Bristol-Myers Squibb Company (BMY)is reporting for the quarter ending December 31, 2023. The biomedical (gene) company's consensus earnings per share forecast from the 10 analysts that follow the stock is $1.52. This value represents a 16.48% decrease compared to the same quarter last year. BMY missed the consensus earnings per share in the 2nd calendar quarter of 2023 by -12.06%. Zacks Investment Research reports that the 2023 Price to Earnings ratio for BMY is 6.60 vs. an industry ratio of -1.60, implying that they will have a higher earnings growth than their competitors in the same industry.
The Cigna Group (CI)is reporting for the quarter ending December 31, 2023. The hmo company's consensus earnings per share forecast from the 10 analysts that follow the stock is $6.52. This value represents a 31.45% increase compared to the same quarter last year. In the past year CI has beat the expectations every quarter. The highest one was in the 3rd calendar quarter where they beat the consensus by 1.65%. Zacks Investment Research reports that the 2023 Price to Earnings ratio for CI is 12.13 vs. an industry ratio of 22.50.
Aon plc (AON)is reporting for the quarter ending December 31, 2023. The insurance brokers company's consensus earnings per share forecast from the 11 analysts that follow the stock is $4.07. This value represents a 4.63% increase compared to the same quarter last year. Zacks Investment Research reports that the 2023 Price to Earnings ratio for AON is 20.83 vs. an industry ratio of 21.20.
Charter Communications, Inc. (CHTR)is reporting for the quarter ending December 31, 2023. The cable tv company's consensus earnings per share forecast from the 8 analysts that follow the stock is $8.93. This value represents a 16.12% increase compared to the same quarter last year. Zacks Investment Research reports that the 2023 Price to Earnings ratio for CHTR is 11.57 vs. an industry ratio of 7.50, implying that they will have a higher earnings growth than their competitors in the same industry.
W.W. Grainger, Inc. (GWW)is reporting for the quarter ending December 31, 2023. The industrial services company's consensus earnings per share forecast from the 7 analysts that follow the stock is $8.03. This value represents a 12.46% increase compared to the same quarter last year. In the past year GWW has beat the expectations every quarter. The highest one was in the 3rd calendar quarter where they beat the consensus by 6.55%. Zacks Investment Research reports that the 2023 Price to Earnings ratio for GWW is 24.63 vs. an industry ratio of 14.80, implying that they will have a higher earnings growth than their competitors in the same industry.
Imperial Oil Limited (IMO)is reporting for the quarter ending December 31, 2023. The consensus earnings per share forecast from the 2 analysts that follow the stock is $1.55. IMO reported earnings of $2.11 per share for the same quarter a year ago; representing a a decrease of -26.54%. In the past year IMO has met analyst expectations once and beat the expectations the other three quarters. LyondellBasell Industries NV (LYB)is reporting for the quarter ending December 31, 2023. The chemical company's consensus earnings per share forecast from the 7 analysts that follow the stock is $1.29. This value represents a no change for the same quarter last year. In the past year LYB has beat the expectations every quarter. The highest one was in the 3rd calendar quarter where they beat the consensus by 24.24%. Zacks Investment Research reports that the 2023 Price to Earnings ratio for LYB is 10.86 vs. an industry ratio of 16.70.
Church & Dwight Company, Inc. (CHD)is reporting for the quarter ending December 31, 2023. The cleaning company's consensus earnings per share forecast from the 11 analysts that follow the stock is $0.64. This value represents a 3.23% increase compared to the same quarter last year. In the past year CHD has beat the expectations every quarter. The highest one was in the 3rd calendar quarter where they beat the consensus by 8.82%. Zacks Investment Research reports that the 2023 Price to Earnings ratio for CHD is 31.60 vs. an industry ratio of 23.40, implying that they will have a higher earnings growth than their competitors in the same industry.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
